Skip to main content

Akoya Biosciences, Inc. (AKYA)

NASDAQ: AKYA · IEX Real-Time Price · USD
15.72 -1.49 (-8.66%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap584.13M
Revenue (ttm)48.15M
Net Income (ttm)n/a
Shares Out29.97M
EPS (ttm)-2.94
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume76,889
Open16.96
Previous Close17.21
Day's Range15.38 - 17.21
52-Week Range13.95 - 28.96
Betan/a
Analystsn/a
Price Target26.00 (+65.4%)
Est. Earnings DateNov 9, 2021

About AKYA

Akoya Biosciences is an innovative life sciences technology company whose mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single cell resolution, enabling advancements in their understanding of disease progre...

IndustryMedical Instruments & Supplies
IPO DateApr 16, 2021
CEOBrian McKelligon
Employees169
Stock ExchangeNASDAQ
Ticker SymbolAKYA
Full Company Profile

Financial Performance

In 2020, AKYA's revenue was $42.44 million, an increase of 0.49% compared to the previous year's $42.24 million. Losses were -$16.71 million, 13.3% more than in 2019.

Financial Statements

News

Akoya Biosciences Appoints Diagnostics Industry Pioneer Myla Lai-Goldman, MD, to its Board of Directors

MARLBOROUGH, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true pio...

4 days ago - GlobeNewsWire

Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

MARLBOROUGH, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be virtually participating in the Morga...

3 weeks ago - GlobeNewsWire

Akoya Reports 53% Revenue Growth in the Second Quarter of 2021

MARLBOROUGH, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the second quarter ending ...

1 month ago - GlobeNewsWire

Akoya Biosciences to Present at the Canaccord 41st Annual Growth Conference

MARLBOROUGH, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be virtually participating in the Canac...

1 month ago - GlobeNewsWire

Akoya to Report Second Quarter 2021 Financial Results on August 10, 2021

MARLBOROUGH, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the secon...

2 months ago - GlobeNewsWire

Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial B...

Results from the study provide evidence of standardization of an automated spatial biology workflow, based on the company's Phenoptics™ multiplex immunofluorescence (mIF) platform, for clinical and tran...

2 months ago - GlobeNewsWire

CrestOptics Selected by Akoya Biosciences for Spatial Biology Collaboration

ROME, Italy--(BUSINESS WIRE)--CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced that it ha...

2 months ago - Business Wire

Akoya to Partner with Nikon, CrestOptics and Andor to Enable New Spatial Biology Applications through the Imaging Inn...

Company plans to work with multiple microscope partners to broaden access to the CODEX® solution for single-cell, multiplexed imaging Company plans to work with multiple microscope partners to broaden a...

2 months ago - GlobeNewsWire

Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors

MARLBOROUGH, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced the appointment of diagnostics industry leader Scott Mendel to...

3 months ago - GlobeNewsWire

Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping Capabilities

CODEX's single-cell, multiplex imaging capabilities to be included in Chan Zuckerberg Initiative grantee toolkit to help fuel the next wave of biological discoveries CODEX's single-cell, multiplex imagi...

3 months ago - GlobeNewsWire

Akoya Announces Publication of New Immunotherapy Biomarker Signature in Science, Leveraging Principles of Astronomy a...

Investigators at Johns Hopkins University (JHU) used AstroPath to identify and validate biomarkers for accurate prediction of long-term response to immune checkpoint inhibitors in advanced melanoma

3 months ago - GlobeNewsWire

Akoya Set to Join Russell 3000® Index

MARLBOROUGH, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, is set to join the broad-market Russell 3000® Index at the conclusio...

3 months ago - GlobeNewsWire

Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology

Partnership aims to leverage spatial biology data, generated on Akoya's Phenoptics™ platform, to inform and guide drug development programs Partnership aims to leverage spatial biology data, generated o...

3 months ago - GlobeNewsWire

Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical Ap...

Company launches Advanced Biopharma Solutions (ABS), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials Company launches Advanced Biopharma Solut...

3 months ago - GlobeNewsWire

Akoya Reports First Quarter 2021 Financial Results and Issues Full Year 2021 Guidance

MARLBOROUGH, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first quarter ending Ma...

4 months ago - GlobeNewsWire

Akoya and ZEISS to Co-Market Innovative CODEX® Spatial Biology Workflow

The partnership brings together one of the world's premier microscopy vendors and Akoya's high-parameter CODEX® System for advancing the emerging field of spatial phenotyping and discovery The partnersh...

4 months ago - GlobeNewsWire

Akoya to Report First Quarter 2021 Financial Results on May 18, 2021

MARLBOROUGH, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first ...

4 months ago - GlobeNewsWire

Akoya Biosciences Begins Accepting Applications for First-of-its-Kind Imaging Innovators (I²) Network

Seeking researchers interested in pushing the boundaries of spatial biology and discovery through the CODEX® system's open, accessible interface Seeking researchers interested in pushing the boundaries ...

4 months ago - GlobeNewsWire

DLA Piper advises Akoya Biosciences in its US$151 million initial public offering

NEW YORK, May 3, 2021 /PRNewswire/ -- DLA Piper represented Akoya Biosciences, Inc. (Nasdaq: AKYA) in its recent initial public offering of 7,567,000 shares of its common stock at a price of $20 per sha...

4 months ago - PRNewsWire

Akoya Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Addition...

MARLBOROUGH, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the closing of its initial public offering of 7,567...

5 months ago - GlobeNewsWire

Akoya Biosciences Announces Pricing of Initial Public Offering

MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580...

5 months ago - GlobeNewsWire

Akoya Biosciences IPO Registration Document (S-1)

Akoya Biosciences, Inc. has filed to go public with an IPO on the NASDAQ.

5 months ago - SEC